Identification of a rat bone marrow-derived dendritic cell population which secretes both IL-10 and IL-12: Evidence against a reciprocal relationship between IL-10 and IL-12 secretion

Immunobiology

Volumn 211, Issue 5, 2006, Pages 391-402

  Muthana, Munitta ^a   Fairburn, Barbara ^a   Mirza, Shabana ^a   Slack, Laura K ^a   Hopkinson, Kay ^a   Pockley, Alan G ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Cellular activation; Co stimulation; Cytokines; Dendritic cells; Rat

Indexed keywords

CD3 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; NEUTRALIZING ANTIBODY; PROTEIN P40; PROTEIN P70;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL POPULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; GEL ELECTROPHORESIS; IMMUNE RESPONSE; IMMUNOPRECIPITATION; INCUBATION TIME; LYMPHOCYTE CULTURE; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RAT; REGULATORY MECHANISM; T LYMPHOCYTE;

EID: 33646583533     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2006.02.001     Document Type: Article

References (73)

1. Abdi K. IL-12: the role of p40 versus p75. Scand. J. Immunol. 56 (2002) 1-11
2. Anderson L., and Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18 (1997) 533-537
3. Anderson C.F., Lucas M., Gutierrez-Kobeh L., Field A.E., and Mosser D.M. T cell biasing by activated dendritic cells. J. Immunol. 173 (2004) 955-961
4. Aste-Amezaga M., Ma X., Sartori A., and Trinchieri G. Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J. Immunol. 160 (1998) 5936-5944
5. Bai L., Feuerer M., Beckhove P., Umansky V., and Schirrmacher V. Generation of dendritic cells from human bone marrow mononuclear cells: advantages for clinical application in comparison to peripheral blood monocyte derived cells. Int. J. Oncol. 20 (2002) 247-253
6. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
7. Bayry J., Lacroix-Desmazes S., Carbonneil C., Misra N., Donkova V., Pashov A., Chevailler A., Mouthon L., Weill B., Bruneval P., Kazatchkine M.D., and Kaveri S.V. Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. Blood 101 (2003) 758-765
8. Brenan M., and Puklavec M. The MRC OX-62 antigen: a useful marker in the purification of rat veiled cells with the biochemical properties of an integrin. J. Exp. Med. 175 (1992) 1457-1465
9. Bright J.J., Musuro B.F., Du C., and Sriram S. Expression of IL-12 in CNS and lymphoid organs of mice with experimental allergic encephalitis. J. Neuroimmunol. 82 (1998) 22-30
10. Brissette-Storkus C.S., Kettel J.C., Whitham T.F., Giezeman-Smits K.M., Villa L.A., Potter D.M., and Chambers W.H. Flt-3 ligand (FL) drives differentiation of rat bone marrow-derived dendritic cells expressing OX62 and/or CD161 (NKR-P1). J. Leuk. Biol. 71 (2002) 941-949
11. Bucht A., Larsson P., Weisbrot L., Thorne C., Pisa P., Smedegard G., Keystone E.C., and Gronberg A. Expression of interferon-gamma (IFN-g), IL-10, IL-12 and transforming growth factor-beta (TGF-b) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA). Clin. Exp. Immunol. 103 (1996) 357-367
12. Caux C., Massacrier C., Vanbervliet B., Barthelemy C., Liu Y.J., and Banchereau J. Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells. Int. Immunol. 6 (1994) 1177-1185
13. Cavani A., Nasorri F., Prezzi C., Sebastiani S., Albanesi C., and Girolomoni G. Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J. Invest. Dermatol. 114 (2000) 295-302
14. de Saint-Vis B., Fugier-Vivier I., Massacrier C., Gaillard C., Vanbervliet B., Ait-Yahia S., Banchereau J., Liu Y.J., Lebecque S., and Caux C. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J. Immunol. 160 (1998) 1666-1676
15. de Smedt T., van Mechelen M., de Becker G., Urbain J., Leo O., and Moser M. Effect of interleukin-10 on dendritic cell maturation and function. Eur. J. Immunol. 27 (1997) 1229-1235
16. Delamarre L., Holcombe H., and Mellman I. Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation. J. Exp. Med. 198 (2003) 111-122
17. Elkins K.L., Cooper A., Colombini S.M., Cowley S.C., and Kieffer T.L. In vivo clearance of an intracellular bacterium, Francisella tularensis LVS, is dependent on the p40 subunit of interleukin-12 (IL-12) but not on IL-12 p70. Infect. Immun. 70 (2002) 1936-1948
18. Fassbender K., Ragoschke A., Rossol S., Schwartz A., Mielke O., Paulig A., and Hennerici M. Increased release of interleukin-12p40 in MS: association with intracerebral inflammation. Neurology 51 (1998) 753-758
19. Gallucci S., Lolkema M., and Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nature Med. 11 (1999) 1249-1255
20. Gately M.K., Renzetti L.M., Magram J., Stern A.S., Adorini L., Gubler U., and Presky D.H. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Ann. Rev. Immunol. 16 (1998) 495-521
21. Gattorno M., Picco P., Vignola S., Stalla F., Buoncompagni A., and Pistoia V. Serum interleukin 12 concentration in juvenile chronic arthritis. Ann. Rheum. Dis. 57 (1998) 425-428
22. Gillessen S., Carvajal D., Ling P., Podlaski F.J., Stremlo D.L., Familletti P.C., Gubler U., Presky D.H., Stern A.S., and Gately M.K. Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur. J. Immunol. 25 (1995) 200-206
23. Goodridge H.S., Harnett W., Liew F.Y., and Harnett M.M. Differential regulation of interleukin-12 p40 and p35 induction via Erk mitogen-activated protein kinase-dependent and -independent mechanisms and the implications for bioactive IL-12 and IL-23 responses. Immunology 109 (2003) 415-425
24. Groux H., Bigler M., de Vries J.E., and Roncarolo M.G. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J. Exp. Med. 184 (1996) 19-29
25. Gubler U., Chua A.O., Schoenhaut D.S., Dwyer C.M., McComas W., Motyka R., Nabavi N., Wolitzky A.G., Quinn P.M., and Familletti P.C. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA 88 (1991) 4143-4147
26. Gygi S.P., Rochon Y., Franza B.R., and Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol. Cell Biol. 19 (1999) 1720-1730
27. Heremans H., Dillen C., Groenen M., Matthys P., and Billiau A. Role of endogenous interleukin-12 (IL-12) in induced and spontaneous relapses of experimental autoimmune encephalomyelitis in mice. Eur. Cytokine Network 10 (1999) 171-180
28. Hino A., Kweon M.N., Fujihashi K., McGhee J.R., and Kiyono H. Pathological role of large intestinal IL-12p40 for the induction of Th2-type allergic diarrhea. Am. J. Pathol. 164 (2004) 1327-1335
29. Hölscher C. The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases. Med. Microbiol. Immunol. (Berl.) 193 (2004) 1-17
30. Hölscher C., Atkinson R.A., Arendse B., Brown N., Myburgh E., Alber G., and Brombacher F. A protective and agonistic function of IL-12p40 in mycobacterial infection. J. Immunol. 167 (2001) 6957-6966
31. Huang L.Y., Reis e Sousa C., Itoh Y., Inman J., and Scott D.E. IL-12 induction by a TH1-inducing adjuvant in vivo: dendritic cell subsets and regulation by IL-10. J. Immunol. 167 (2001) 1423-1430
32. Hubert F.X., Voisine C., Louvet C., Heslan M., and Josien R. Rat plasmacytoid dendritic cells are an abundant subset of MHC Class II+ CD4+ CD11b- OX62- and Type I IFN-producing cells that exhibit selective expression of Toll-like receptors 7 and 9 and strong responsiveness to CpG. J. Immunol. 172 (2004) 7485-7494
33. Jiang H.R., Muckersie E., Robertson M., Xu H., Liversidge J., and Forrester J.V. Secretion of interleukin-10 or interleukin-12 by LPS-activated dendritic cells is critically dependent on time of stimulus relative to initiation of purified DC culture. J. Leuk. Biol. 72 (2002) 978-985
34. Kalinski P., Smits H.H., Schuitemaker J.H., Vieira P.L., van Eijk M., de Jong E.C., Wierenga E.A., and Kapsenberg M.L. IL-4 is a mediator of IL-12p70 induction by human Th2 cells: reversal of polarized Th2 phenotype by dendritic cells. J. Immunol. 165 (2000) 1877-1881
35. Kapsenberg M.L. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 3 (2003) 984-993
36. Kato K., Shimozato O., Hoshi K., Wakimoto H., Hamada H., Yagita H., and Okumura K. Local production of the p40 subunit of interleukin 12 suppresses T-helper 1-mediated immune responses and prevents allogeneic myoblast rejection. Proc. Natl. Acad. Sci. USA 93 (1996) 9085-9089
37. Khochbin S., Gorka C., and Lawrence J.J. Multiple control level governing H10 mRNA and protein accumulation. FEBS Lett. 283 (1991) 65-67
38. Kikuchi K., Yanagawa Y., Aranami T., Iwabuchi C., Iwabuchi K., and Onoe K. Tumour necrosis factor-α but not lipopolysaccharide enhances preference of murine dendritic cells for Th2 differentiation. Immunology 108 (2003) 42-49
39. Kobayashi M., Fitz L., Ryan M., Hewick R.M., Clark S.C., Chan S., Loudon R., Sherman F., Perussia B., and Trinchieri G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170 (1989) 827-845
40. Koch F., Stanzl U., Jennewein P., Janke K., Heufler C., Kampgen E., Romani N., and Schuler G. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184 (1996) 741-746
41. Krakowski M.L., and Owens T. The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis. Eur. J. Immunol. 27 (1997) 2840-2847
42. Lankford C.S., and Frucht D.M. A unique role for IL-23 in promoting cellular immunity. J. Leuk. Biol. 73 (2003) 49-56
43. Lehmann J., Bellmann S., Werner C., Schroder R., Schutze N., and Alber G. IL-12p40-dependent agonistic effects on the development of protective innate and adaptive immunity against Salmonella enteritidis. J. Immunol. 167 (2001) 5304-5315
44. Ling P., Gately M.K., Gubler U., Stern A.S., Lin P., Hollfelder K., Su C., Pan Y.C., and Hakimi J. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J. Immunol. 154 (1995) 116-127
45. Lutz M.B., and Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?. Trends Immunol. 23 (2002) 445-449
46. Mattner F., Ozmen L., Podlaski F.J., Wilkinson V.L., Presky D.H., Gately M.K., and Alber G. Treatment with homodimeric interleukin-12 (IL-12) p40 protects mice from IL-12-dependent shock but not from tumor necrosis factor alpha-dependent shock. Infect. Immun. 65 (1997) 4734-4737
47. Morel A.S., Quaratino S., Douek D.C., and Londei M. Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step. Eur. J. Immunol. 27 (1997) 26-34
48. Murphy T.L., Cleveland M.G., Kulesza P., Magram J., and Murphy K.M. Regulation of interleukin 12 p40 expression through an NF-κB half-site. Mol. Cell Biol. 15 (1995) 5258-5267
49. Muthana M., Fairburn B., Mirza S., Slack L.K., and Pockley A.G. Systematic evaluation of the conditions required for the generation of immature rat bone marrow-derived dendritic cells and their phenotypic and functional characterization. J. Immunol. Methods 294 (2004) 165-179
50. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., Vega F., Yu N., Wang J., Singh K., Zonin F., Vaisberg E., Churakova T., Liu M., Gorman D., Wagner J., Zurawski S., Liu Y., Abrams J.S., Moore K.W., Rennick D., de Waal-Malefyt R., Hannum C., Bazan J.F., and Kastelein R.A. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13 (2000) 715-725
51. Piccotti J.R., Chan S.Y., Li K., Eichwald E.J., and Bishop D.K. Differential effects of IL-12 receptor blockade with IL-12 p40 homodimer on the induction of CD4+ and CD8+ IFN-γ-producing cells. J. Immunol. 158 (1997) 643-648
52. Pierre P., Turley S.J., Gatti E., Hull M., Meltzer J., Mirza A., Inaba K., Steinman R.M., and Mellman I. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388 (1997) 787-792
53. Podlaski F.J., Nanduri V.B., Hulmes J.D., Pan Y.C., Levin W., Danho W., Chizzonite R., Gately M.K., and Stern A.S. Molecular characterization of interleukin 12. Arch. Biochem. Biophys. 294 (1992) 230-237
54. Powell T.J., Jenkins C.D., Hattori R., and MacPherson G.G. Rat bone marrow-derived dendritic cells, but not ex vivo dendritic cells, secrete nitric oxide and can inhibit T-cell proliferation. Immunology 109 (2003) 197-208
55. Rautajoki K., Nyman T.A., and Lahesmaa R. Proteome characterization of human T helper 1 and 2 cells. Proteomics 4 (2004) 84-92
56. Rivas-Carvalho A., Meraz-Ríos M.A., Santos-Argumedo L., Bajaña S., Soldevila G., Moreno-García M.E., and Sánchez-Torres C. CD16+ human monocyte-derived dendritic cells matured with different and unrelated stimuli promote similar allogeneic Th2 responses: regulation by pro- and anti-inflammatory cytokine. Int. Immunol. 16 (2004) 1251-1263
57. Rothe H., O'Hara Jr. R.M., Martin S., and Kolb H. Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2. Diabetologia 40 (1997) 641-646
58. Rousseau D., Khochbin S., Gorka C., and Lawrence J.J. Induction of H1(0)-gene expression in B16 murine melanoma cells. Eur. J. Biochem. 208 (1992) 775-779
59. Shortman K., and Liu Y.J. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2 (2002) 151-161
60. Shortman K., and Wu L. Are dendritic cells end cells?. Nature Immunol. 5 (2004) 1105-1106
61. Snijders A., van der Pouw Kraan T.C., Engel M., Wormmeester J., Widjaja P., Zonneveld I.M., Bos J.D., and Kapsenberg M.L. Enhanced prostaglandin E2 production by monocytes in atopic dermatitis (AD) is not accompanied by enhanced production of IL-6, IL-10 or IL-12. Clin. Exp. Immunol. 111 (1998) 472-476
62. Stallmach A., Marth T., Weiss B., Wittig B.M., Hombach A., Schmidt C., Neurath M., Zeitz M., Zeuzem S., and Abken H. An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn's disease and experimental colitis in vivo. Gut 53 (2004) 339-345
63. Steinbrink K., Jonuleit H., Muller G., Schuler G., Knop J., and Enk A.H. Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific energy in CD8+ T cells resulting in a failure to lyse tumor cells. Blood 93 (1999) 1634-1642
64. Steinbrink K., Wolfl M., Jonuleit H., Knop J., and Enk A.H. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159 (1997) 4772-4780
65. Tajima K., Amakawa R., Ito T., Miyaji M., Takebayashi M., and Fukuhara S. Immunomodulatory effects of cyclosporin A on human peripheral blood dendritic cell subsets. Immunology 108 (2003) 321-328
66. Talmor M., Mirza A., Turley S., Mellman I., Hoffman L.A., and Steinman R.M. Generation of large numbers of immature and mature dendritic cells from rat bone marrow cultures. Eur. J. Immunol. 28 (1998) 811-817
67. Trinchieri G. Proinflammatory and immunoregulatory functions of interleukin-12. Int. Rev. Immunol. 16 (1998) 365-396
68. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3 (2003) 133-146
69. Trinité B., Voisine C., Yagita H., and Josien R. A subset of cytolytic dendritic cells in rat. J. Immunol. 165 (2000) 4202-4208
70. van Boxel-Dezaire A.H., Hoff S.C., van Oosten B.W., Verweij C.L., Drager A.M., Ader H.J., van Houwelingen J.C., Barkhof F., Polman C.H., and Nagelkerken L. Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis. Ann. Neurol. 45 (1999) 695-703
71. Windhagen A., Newcombe J., Dangond F., Strand C., Woodroofe M.N., Cuzner M.L., and Hafler D.A. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 182 (1995) 1985-1996
72. Xia C.-Q., and Kao K.J. Suppression of interleukin-12 production through endogenously secreted interleukin-10 in activated dendritic cells: involvement of activation of extracellular signal-regulated protein kinase. Scand. J. Immunol. 58 (2003) 23-32
73. Yasuda H., Nagata M., Arisawa K., Yoshida R., Fujihira K., Okamoto N., Moriyama H., Miki M., Saito I., Hamada H., Yokono K., and Kasuga M. Local expression of immunoregulatory IL-12p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice. J. Clin. Invest. 102 (1998) 1807-1814